News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advaxis, Inc. Announces Filing of Proxy Statement Supplement and New Annual Meeting Date



5/23/2013 7:50:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has filed a Form DEFR14A, proxy statement supplement, with the U.S. Securities and Exchange Commission. The filing revises certain proposals in the proxy statement originally filed on April 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES